During the past decade, Franziskus-Krankenhaus Berlin conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Franziskus-Krankenhaus Berlin" #1 sponsor was "GWT-TUD GmbH" with 2 trials, followed by "Molnlycke Health Care AB" with 2 trials sponsored, "Pluristem Ltd." with 2 trials sponsored, "Association of Urologic Oncology (AUO)" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Franziskus-Krankenhaus Berlin" #1 collaborator was "Syntactx" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "ClinStat GmbH" with 1 trials as a collaborator and "FGK Clinical Research GmbH" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Franziskus-Krankenhaus Berlin" are "Critical Limb Ischemia" (2 trials), "Intermittent Claudication" (2 trials), "Peripheral Artery Disease" (2 trials), "Peripheral Vascular Disease" (2 trials) and "Abdominal Aortic Aneurysm" (1 trials). Many other conditions were trialed in "Franziskus-Krankenhaus Berlin" in a lesser frequency.

Most popular intervention types in "Franziskus-Krankenhaus Berlin" are "Drug" (5 trials), "Device" (4 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Avance Solo NPWT System" (2 trials), "Placebo" (2 trials), "Active FlowOx™" (1 trials), "Avance Solo Adapt NPWT System" (1 trials) and "Double Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Franziskus-Krankenhaus Berlin" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Franziskus-Krankenhaus Berlin". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Franziskus-Krankenhaus Berlin, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Franziskus-Krankenhaus Berlin, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".